Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04975152
Brief Title: Neoadjuvant Cemiplimab in Stage I-II Merkel Cell Carcinoma: Safety and Biomarker Analysis

First Submitted : July 22, 2021
First Submitted that Met QC Criteria : July 22, 2021
First Posted : July 23, 2021

Last Update Submitted that Met QC Criteria : August 4, 2021
Last Update Posted : August 5, 2021